Genetic Testing for Breast, Ovarian, Pancreatic and Prostate Cancers – GeneBOPP

Protocol # :
Breast Cancer
Ovarian Cancer
Pancreatic Cancer
Metastatic Prostate Cancer
Not Applicable
Disease Sites
Principal Investigator
Rana, Huma
Site Research Nurses
Brule, Maurice, N.
Cronis, Charles, Lewis
Fleming, Norah, Michelle
Freeman, Stefani, Danielle
Gentile, Alissa
Ginter, Lindsey
Hixon, Nicole, R.
Kosinski, Michelle
Loeser, Wendy
Piper, Audrey, L.

Trial Description

This study is evaluating the effect of two pre-test education methods on participants
interested in genetic testing for hereditary cancer risk.

Eligibility Requirements

Inclusion Criteria:

- Potentially eligible participants will be identified via medical record screening
and/or in accordance with their clinical visit. A HIPAA waiver of authorization will
be obtained by the enrolling Institution as needed to have access to the subject's
medical record information for screening of eligibility.

- A member of the study team will approach the potentially eligible participant in
clinic and discuss the trial. Potentially eligible participants may choose to discuss
participation further with their physician at their appointment

- Age ≥ 18 years

- Breast, ovarian, pancreatic, or metastatic prostate cancer

- No prior cancer genetic testing

- Ability to understand and the willingness to sign an informed consent document

Exclusion Criteria:

- Pregnant

- Prisoners

- Inability to understand English as a spoken language in a healthcare context

- Known hematologic malignancy (e.g. CLL)